Ghostwriting, Industry Influence at Heart of Ongoing Inquiries

As the financial relationship between researchers and the device and drug industries continues to come under fire, the HHS Office of Inspector General (OIG) is calling on NIH to ramp up its oversight of potential conflicts of interest in research it funds. An OIG report recommends that NIH require institutions to collect information on all significant financial interests — not just those researchers decide are applicable — and develop guidance on verifying researchers’ financial interests.
Clinical Trials Advisor